PHS
PFM Health Sciences’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-926,424
| Closed | -$11.4M | – | 69 |
|
|
2025
Q1 | $11.4M | Buy |
926,424
+719,553
| +348% | +$8.84M | 0.83% | 28 |
|
|
2024
Q4 | $2.73M | Sell |
206,871
-217,039
| -51% | -$2.87M | 0.17% | 58 |
|
|
2024
Q3 | $8.16M | Buy |
423,910
+36,553
| +9% | +$704K | 0.46% | 43 |
|
|
2024
Q2 | $7.95M | Sell |
387,357
-271,337
| -41% | -$5.57M | 0.39% | 46 |
|
|
2024
Q1 | $15.7M | Buy |
658,694
+63,171
| +11% | +$1.5M | 0.74% | 40 |
|
|
2023
Q4 | $12.9M | Sell |
595,523
-2,119,712
| -78% | -$45.8M | 0.77% | 43 |
|
|
2023
Q3 | $39.4M | Buy |
2,715,235
+542,798
| +25% | +$7.88M | 1.86% | 25 |
|
|
2023
Q2 | $45.5M | Buy |
2,172,437
+225,785
| +12% | +$4.73M | 1.77% | 21 |
|
|
2023
Q1 | $41.1M | Buy |
1,946,652
+132,018
| +7% | +$2.79M | 1.82% | 19 |
|
|
2022
Q4 | $46.2M | Buy |
1,814,634
+525,561
| +41% | +$13.4M | 1.65% | 20 |
|
|
2022
Q3 | $31M | Buy |
1,289,073
+708,305
| +122% | +$17M | 1.12% | 41 |
|
|
2022
Q2 | $11.2M | Sell |
580,768
-1,462,609
| -72% | -$28.1M | 0.43% | 55 |
|
|
2022
Q1 | $35.5M | Sell |
2,043,377
-60,135
| -3% | -$1.05M | 1.33% | 35 |
|
|
2021
Q4 | $46M | Buy |
2,103,512
+246,774
| +13% | +$5.4M | 1.57% | 28 |
|
|
2021
Q3 | $35.5M | Sell |
1,856,738
-288,143
| -13% | -$5.51M | 1.04% | 36 |
|
|
2021
Q2 | $36.8M | Buy |
2,144,881
+660,654
| +45% | +$11.3M | 1.15% | 33 |
|
|
2021
Q1 | $33.2M | Buy |
+1,484,227
| New | +$33.2M | 1.01% | 36 |
|